Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 144449-86-5 mage 1nonapeptide in China, also supports custom service. Welcome to wholesale bulk high quality cas 144449-86-5 mage 1nonapeptide from our factory. Contact us for more details.
| Description | The MAGE-A1 nine-mer, an HLA-restricted CD8+ epitope; MAGE-A1 was among the first tumor-specific rejection antigens discovered. |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| MAGE-1 Antigen (161-169) Nonapeptide (human, MZ2-E epitope) | MAGE-1 nonapeptide; MAGE-A1 (161-169); EADPTGHSY; MZ2-E / MAGE-1.A1 epitope | Cancer-testis antigen,MAGE-A1,HLA-A1-restricted,CTL epitope,MZ2-E,melanoma,cancer vaccine,tumor immunology | H-Glu-Ala-Asp-Pro-Thr-Gly-His-Ser-Tyr-OH; 9-mer from residues 161-169 of human MAGE-A1 (MAGE-1, UniProt P43355), the MZ2-E (MAGE-1.A1) HLA-A1-restricted CTL epitope; linear peptide with free N-terminal amine / free C-terminal carboxyl; contains Tyr (light-sensitive); distinct from MAGE-A1(257-265)=KVLEYVIKV (HLA-A2, CAS 160213-30-9) | C41H57N11O17 | 975.39 | 975.97 | Acetate salt (Howei lists acetate salt; per supplier COA) | 9 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-MAGE1A-01 | White to off-white powder | Store at -20°C, dry, sealed and protected from light (Tyr-containing); acetate salt, keep dry | Short-term storage at 2-8°C, light-protected and dry; use within 2-4 weeks | Acidic E/D residues confer good water solubility; dissolve directly in sterile water/PBS; light-sensitive Tyr - protect from light, prepare fresh, avoid repeated freeze-thaw | powder stable at -20°C when dry, sealed and light-protected; weigh quickly after opening and reseal (hygroscopic) |
Functional Description
| Product Code | Frontend Short Summary | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-MAGE1A-01 | The HLA-A1-restricted CTL epitope EADPTGHSY (human MAGE-A1 residues 161-169; MZ2-E / MAGE-1.A1), the first molecularly identified human tumor rejection antigen epitope, used in cancer vaccines and CTL immune monitoring. | Source: 9-mer from residues 161-169 of the human MAGE-A1 (MAGE-1) cancer-testis antigen; MAGE-A1 was among the first tumor rejection antigens identified (from the melanoma line MZ2-MEL). Epitope property: HLA-A1-restricted CTL epitope (MZ2-E antigen, reported by Boel et al. 1995); encoded by exon 3 of MAGE-1, recognized by autologous CTLs from HLA-A1+ melanoma patients - the first human tumor rejection epitope defined at the molecular level by T cells. Sequence relationships: this HLA-A1 epitope of MAGE-A1 is a different peptide from the previously handled MAGE-A1(257-265)=KVLEYVIKV (HLA-A*0201 epitope, CAS 160213-30-9); they must not be confused. Applications: HLA-A1/peptide tetramers and ELISPOT to quantify MAGE-A1-specific CD8+ T cells, peptide/DC vaccines to induce anti-tumor CTLs, tumor immune monitoring and epitope-vaccine design, multivalent vaccines with other cancer-testis peptides. | Tumor immunology,melanoma,cancer vaccines,CTL epitopes,cancer-testis antigens,immune monitoring | MAGE-A1(161-169) epitope presented by HLA-A1 (HLA-A*01); CD8+ T-cell TCR; human MAGE-A1 protein |
Hot Tags: cas 144449-86-5 mage 1nonapeptide, China cas 144449-86-5 mage 1nonapeptide manufacturers, suppliers, factory, 124454-83-7, 2293841-58-2, Ac MBP 1 11 , CAS 199727 68 9, epitope peptides, Nucleoprotein 118 126
